secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2022-02-03T23:59:59+00:00
Accession:  0001437749-22-002307
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q4 revenue $23.8M, operating loss $1.2M; supply chain delays impacted results
--------------------------------------------------------------------------------

- GAAP net loss $1.1M ($0.07 loss per share) vs net income $2.1M ($0.13 EPS) in Q4 2020.
- Revenue down 18% to $23.8M; delayed shipments from supply chain issues reduced revenue by ~$5.4M.
- Backlog grew 35% core YoY to >$53M; over $63M including Excell acquisition.
- FY2021 GAAP EPS ($0.01), Adjusted EPS ($0.02) vs FY2020 GAAP EPS $0.33, Adjusted EPS $0.41.
- Acquisition of Excell Battery Group in Dec 2021 added initial revenue but also $0.5M in one-time expenses and purchase accounting adjustments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774922002307/0001437749-22-002307-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774922002307/ulbi20220203_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-002307

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer